49 CFR Part 40, Subpart F - Drug Testing Laboratories
- § 40.81 — What laboratories may be used for DOT drug testing?
- § 40.83 — How do laboratories process incoming specimens?
- § 40.85 — What drugs do laboratories test for?
- § 40.87 — What are the cutoff concentrations for drug tests?
- § 40.89 — What is validity testing, and are laboratories required to conduct it?
- § 40.91 — What validity tests must laboratories conduct on primary specimens?
- § 40.93 — What criteria do laboratories use to establish that a specimen is dilute or substituted?
- § 40.95 — What are the adulterant cutoff concentrations for initial and confirmation tests?
- § 40.96 — What criteria do laboratories use to establish that a specimen is invalid?
- § 40.97 — What do laboratories report and how do they report it?
- § 40.99 — How long does the laboratory retain specimens after testing?
- § 40.101 — What relationship may a laboratory have with an MRO?
- § 40.103 — What are the requirements for submitting blind specimens to a laboratory?
- § 40.105 — What happens if the laboratory reports a result different from that expected for a blind specimen?
- § 40.107 — Who may inspect laboratories?
- § 40.109 — What documentation must the laboratory keep, and for how long?
- § 40.111 — When and how must a laboratory disclose statistical summaries and other information it maintains?
- § 40.113 — Where is other information concerning laboratories found in this regulation?
Title 49 published on 2015-10-01.
No entries appear in the Federal Register after this date, for 49 CFR Part 40.